[go: up one dir, main page]

NO973116L - Thrombolytic agents - Google Patents

Thrombolytic agents

Info

Publication number
NO973116L
NO973116L NO973116A NO973116A NO973116L NO 973116 L NO973116 L NO 973116L NO 973116 A NO973116 A NO 973116A NO 973116 A NO973116 A NO 973116A NO 973116 L NO973116 L NO 973116L
Authority
NO
Norway
Prior art keywords
thrombolytic agents
agent
amidino
imidazol
dihydro
Prior art date
Application number
NO973116A
Other languages
Norwegian (no)
Other versions
NO973116D0 (en
Inventor
Hiroyuki Uchiyama
Masahiro Iwaki
Original Assignee
Torii Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from HU9800558A external-priority patent/HUT77739A/en
Priority claimed from PCT/JP1995/000001 external-priority patent/WO1996020706A1/en
Application filed by Torii Pharmaceutical Co Ltd filed Critical Torii Pharmaceutical Co Ltd
Priority to NO973116A priority Critical patent/NO973116L/en
Publication of NO973116D0 publication Critical patent/NO973116D0/en
Publication of NO973116L publication Critical patent/NO973116L/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Det beskrives et trombolytisk middel som kan bli tilført oralt, der det nevnte middel omfatter 6-amidino-2-naftyl-4-[(4,5-dihydro-1 H-imidazol-2-yl)-amino]benzoat eller et farmasøytisk akseptabelt syreaddisjonssalt av dette.There is disclosed a thrombolytic agent which may be administered orally, said agent comprising 6-amidino-2-naphthyl-4 - [(4,5-dihydro-1H-imidazol-2-yl) amino] benzoate or a pharmaceutical acceptable acid addition salt thereof.

NO973116A 1995-01-05 1997-07-04 Thrombolytic agents NO973116L (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
NO973116A NO973116L (en) 1995-01-05 1997-07-04 Thrombolytic agents

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
HU9800558A HUT77739A (en) 1995-01-05 1995-01-05 Orally administered thrombolytic agent containing a dihydroimidazole derivative
PCT/JP1995/000001 WO1996020706A1 (en) 1995-01-05 1995-01-05 Thrombolytic agent
NO973116A NO973116L (en) 1995-01-05 1997-07-04 Thrombolytic agents

Publications (2)

Publication Number Publication Date
NO973116D0 NO973116D0 (en) 1997-07-04
NO973116L true NO973116L (en) 1997-09-04

Family

ID=26318300

Family Applications (1)

Application Number Title Priority Date Filing Date
NO973116A NO973116L (en) 1995-01-05 1997-07-04 Thrombolytic agents

Country Status (1)

Country Link
NO (1) NO973116L (en)

Also Published As

Publication number Publication date
NO973116D0 (en) 1997-07-04

Similar Documents

Publication Publication Date Title
FI942092A7 (en) Government-approved product
IS5129A (en) Arylsulfonylamino hydroxamic acid derivatives, their use, together with pharmaceutical preparations
IS5130A (en) Arylsulfonylamino hydroxamic acid derivatives, their use, together with pharmaceutical preparations
NO306253B1 (en) Arylsulfonyl hydroxamic acid derivatives, their use and pharmaceutical preparation
RU95101048A (en) Prolineamide derivatives and pharmcomposition based thereon
AR027162A1 (en) COMPOUNDS OF 2-PHENYL-3-PHENOXYL-PHENYLTIO-BENZOTIOFEN, PHARMACEUTICALLY ACCEPTABLE SALTS OF THE SAME AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
DE69511089D1 (en) METALLOPROTEINASE INHIBITORS
NO2013019I2 (en) Aliskiren or a pharmaceutically acceptable salt thereof, and hydrochlorothiazide or a pharmaceutically acceptable salt thereof.
FI951901L (en) Stable extended-release, orally administered formulation
EP1486207A3 (en) Sulfonated amino acid derivatives and metalloproteinase inhibitors containing the same
DK0753506T3 (en) 6-Dimethylaminomethyl-1-phenyl-cyclohexane compounds as pharmaceutically active substances
DK0780369T3 (en) 1-phenyl-2-dimethylaminomethyl-cyclohexan-1-ol compounds as pharmaceutically active substances
FI962589A0 (en) 2,4-disulfophenylbutylnitron its salts, and their use as pharmaceutical agents
SE9503143D0 (en) New preparation
CA2282513A1 (en) Stabilization of acid sensitive benzimidazoles with amino acid/cyclodextrin combinations
NZ512883A (en) 2-oxoquinoline compounds and medicinal uses thereof
NO962074D0 (en) Amphiphilic derivatives of guanidine
NO953367D0 (en) Use of substituted 4-phenyl-6-amino-nicotinic acid derivatives as drugs
BR0211063A (en) Salts of anticonvulsant derivatives
ITMI931973A1 (en) DERIVATIVES OF 2-AMINO-1,2,3,4-TETRAHYDRO-NAPHTHALENE ACTIVE ON THE CARDIOVASCULAR SYSTEM
ES2062137T3 (en) USE OF 5'-DEOXI-5'-METHYL-THIOADENOSINE, S-ADENOSYLMETIONINE AND ITS SALTS FOR THE PREPARATION OF REDUCING PHARMACEUTICAL COMPOSITIONS OF SEBORRHEA.
NO307048B1 (en) N-methyl-N - [(1S) -1-phenyl-2 - ((3S) -3-hydroxypyrrolidin-1-yl) -ethyl] -2,2-diphenylacetamide hydrochloride, drug containing the compound, use of the drug for the preparation of pharmaceutical preparations, pharmaceutical preparations containing l
NO973116L (en) Thrombolytic agents
KR970061248A (en) 1, 1, 2-triphenylbut-1-ene derivative for the treatment of Alzheimer's disease
SE9403905D0 (en) New formulations

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application